Athira Pharma (ATHA) Earnings Date & Reports

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ATHA is expected to report earnings to fall 53.68% to -17 cents per share on May 08

Athira Pharma ATHA Stock Earnings Reports

Q1'25

Est.

$-0.18

Q4'24

Est.

$-0.38

Q3'24

Missed

by $0.05

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.11

The last earnings report on February 27 showed earnings per share of -37 cents, meeting the estimate of -37 cents. With 201.76K shares outstanding, the current market capitalization sits at 9.76M.

View a ticker or compare two or three

Compare

ATHA